Not applicableUnknownNCT05666011What this trial is testingLaser to Aid in Treatment of Keratosis Pilaris on ArmsWho this might be right forKeratosis Pilaris Goldman, Butterwick, Fitzpatrick and Groff 10
Testing effectiveness (Phase 2)Study completedNCT00006357What this trial is testingSTI571 in Treating Patients With Recurrent or Refractory Soft Tissue SarcomaWho this might be right forEndometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more European Organisation for Research and Treatment of Cancer - EORTC 91
Testing effectiveness (Phase 2)Study completedNCT01055314What this trial is testingTemozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic RhabdomyosarcomaWho this might be right forAdult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Embryonal Rhabdomyosarcoma+3 more National Cancer Institute (NCI) 175
Testing effectiveness (Phase 2)UnknownNCT01883518What this trial is testingAutologous Dendritic Cell Vaccine in Patients With Soft Tissue SarcomaWho this might be right forSarcomaNeoplasms, Connective and Soft Tissue N.N. Petrov National Medical Research Center of Oncology 48
Large-scale testing (Phase 3)Active Not RecruitingNCT04994132What this trial is testingCompare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk RhabdomyosarcomaWho this might be right forAlveolar RhabdomyosarcomaBotryoid-Type Embryonal RhabdomyosarcomaEmbryonal Rhabdomyosarcoma+5 more Children's Oncology Group 118
Post-approval studies (Phase 4)Ended earlyNCT00924950What this trial is testingTaclonex Ointment With Hydrogel Patch Occlusion for the Treatment of PsoriasisWho this might be right forPlaque PsoriasisPsoriasis Vulgaris University of California, San Francisco 35
Not applicableStudy completedNCT01412541What this trial is testingMoxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal ArteriesWho this might be right forFemoral Artery StenosisPopliteal Artery StenosisFemoral Artery Occlusion+1 more C. R. Bard 532
Testing effectiveness (Phase 2)Study completedNCT00003745What this trial is testingChemotherapy in Treating Children With Recurrent or Refractory SarcomasWho this might be right forSarcoma National Cancer Institute (NCI) 125
Large-scale testing (Phase 3)UnknownNCT00379457What this trial is testingCombination Chemotherapy in Treating Young Patients With Nonmetastatic RhabdomyosarcomaWho this might be right forSarcoma European Paediatric Soft Tissue Sarcoma Study Group 600
Testing effectiveness (Phase 2)UnknownNCT03989596What this trial is testingHypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue SarcomasWho this might be right forSarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more Maria Sklodowska-Curie National Research Institute of Oncology 30
Large-scale testing (Phase 3)Looking for participantsNCT05304585What this trial is testingChemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative RhabdomyosarcomaWho this might be right forEmbryonal RhabdomyosarcomaFusion-Negative Alveolar RhabdomyosarcomaSpindle Cell/Sclerosing Rhabdomyosarcoma Children's Oncology Group 205
Testing effectiveness (Phase 2)Study completedNCT01154452What this trial is testingVismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaWho this might be right forAdult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+32 more National Cancer Institute (NCI) 78
Testing effectiveness (Phase 2)Study completedNCT00031915What this trial is testingImatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone SarcomaWho this might be right forChildhood Malignant Fibrous Histiocytoma of BoneSarcoma National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00720174What this trial is testingCixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaWho this might be right forAdult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT00002898What this trial is testingSurgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue SarcomaWho this might be right forChildhood Malignant Fibrous Histiocytoma of BoneSarcoma Societe Internationale d'Oncologie Pediatrique 400
Large-scale testing (Phase 3)Looking for participantsNCT06669013What this trial is testingChemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue SarcomasWho this might be right forBone SarcomaEmbryonal RhabdomyosarcomaAlveolar Rhabdomyosarcoma N.N. Petrov National Medical Research Center of Oncology 40
Early research (Phase 1)Study completedNCT00030784What this trial is testingLiposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue SarcomaWho this might be right forSarcoma European Organisation for Research and Treatment of Cancer - EORTC 28
Testing effectiveness (Phase 2)Study completedNCT00331643What this trial is testingIxabepilone in Treating Young Patients With Refractory Solid TumorsWho this might be right forAdult RhabdomyosarcomaAdult Synovial SarcomaAlveolar Childhood Rhabdomyosarcoma+10 more National Cancer Institute (NCI) 120
Not applicableStudy completedNCT01567046What this trial is testingStudying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue SarcomasWho this might be right forChildhood Alveolar Soft-part SarcomaChildhood AngiosarcomaChildhood Desmoplastic Small Round Cell Tumor+12 more Children's Oncology Group 70
Large-scale testing (Phase 3)UnknownNCT00334854What this trial is testingIfosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue SarcomaWho this might be right forChildhood Malignant Fibrous Histiocytoma of BoneSarcoma European Paediatric Soft Tissue Sarcoma Study Group 250